Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunome, Inc. - Common Stock (NQ:IMNM)

21.55 -0.97 (-4.31%)
Streaming Delayed Price Updated: 12:45 PM EST, Mar 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunome, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
72 Biggest Movers From Yesterday ↗
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.... 
Via Benzinga
News headline image
Immunome's COVID-19 Antibody Neutralizes Two Variant Strains In Animal Studies ↗
Immunome Inc's (NASDAQ: IMNM) three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against SARS-CoV-2 Lambda (C.37) and Delta AY.1/2 (Delta... 
Via Benzinga
Why Immunome's Stock Is Soaring Today ↗
Immunome Inc (NASDAQ:IMNM) is surging Tuesday morning afte... 
Via Benzinga
Thinking About Buying Stock In Immunome, Axsome Or Etsy? ↗
Immunome Inc (NASDAQ:IMNM) shares are trading higher by 9.25% by $32.28 after the ... 
Via Benzinga
News headline image
Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes SARS-CoV-2 Lambda and Delta Plus Variants in Pre-clinical Testing
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Second Quarter 2021 Financial Results
From Immunome, Inc.
Via Business Wire
News headline image
38 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to... 
Via Benzinga
News headline image
28 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares rose 78.2% to $3.67 in pre-market trading after dropping more than 16% on Tuesday. Chembio’s filing recently showed... 
Via Benzinga
News headline image
62 Biggest Movers From Yesterday ↗
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher ↗
Toward the end of trading Tuesday, the Dow traded up 1.83% to 34,583.56 while the NASDAQ rose 1.74% to 14,523.41. The S&P also rose, gaining 1.70% to 4,330.82. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Dow Rises 500 Points as Rally Gains Momentum ↗
Stocks are on a tear midday, as investors shake off delta variant fears and buy the dip in the wake of yesterday's selloff. 
Via Talk Markets
Topics Stocks
News headline image
34 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550. NeuroMetrix, Inc. (NASDAQ: NURO) gained 37.4% to $4.4750 as the company said it received FDA... 
Via Benzinga
News headline image
IMNM Stock: The Covid Treatment News That Has Immunome Soaring Today ↗
IMNM stock is having a great day today. The company is preparing to move forward with expedited testing for its delta variant treatment. 
Via InvestorPlace
News headline image
Mid-Morning Market Update: Markets Open Higher; Philip Morris Posts Mixed Q2 Results ↗
Following the market opening Tuesday, the Dow traded up 1.32% to 34,409.28 while the NASDAQ rose 0.48% to 14,343.85. The S&P also rose, gaining 0.91% to 4,297.39. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Immunome Stock Jumps As COVID-19 Antibody Shows Preclinical Neutralizing Activity Against Delta Variant ↗
Immunome Inc (NASDAQ: IMNM) has announced that its three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against COVI-19 Delta variant... 
Via Benzinga
News headline image
Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing
From Immunome, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... 
Via Benzinga
News headline image
Immunome to Present at the Ladenburg Thalmann 2021 Healthcare Conference
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Appoints Andrew Badley, M.D., to COVID-19 Advisory Board
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D., to Board of Directors
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Present at the Jefferies Virtual Healthcare Conference
From Immunome, Inc.
Via Business Wire
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday after the company announced plans to acquire a Alabama refinery and related... 
Via Benzinga
News headline image
Immunome Secures Additional $4.3M Funding From DoD To Develop COVID-19 Antibody Cocktail ↗
Immunome Inc (NASDAQ: IMNM) has secured additional funding of $4.3 million from the Department of Defense (DoD) for the development of an antibody cocktail (IMM-... 
Via Benzinga
News headline image
Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports First Quarter 2021 Financial Results
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Raises $27M Via Private Equity Placement At 9% ↗
In addition to encouraging preclinical data from the COVID-19 antibody cocktail announced today, Immunome Inc (NASDAQ: IMNM) has entered into a... 
Via Benzinga
News headline image
Immunome's Stock Jumps On Its Antibody Cocktail Neutralizing Multiple COVID-19 Variants In Animal Studies ↗
Immunome Inc (NASDAQ: IMNM) has announced antibody selection for its IMM-BCP-01 antibody cocktail and shared preclinical data showing that IMM-BCP-01 is... 
Via Benzinga
News headline image
Immunome SARS-CoV-2 Antibody Cocktail Neutralizes UK, South Africa, Brazil and California Variants in Preclinical Testing; Progressing Towards IND Filing
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Announces $27 Million Private Placement
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Appoints Corleen Roche as Chief Financial Officer
From Immunome
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.